spin-off

Abbott Is Splitting Off Similac and Pedialyte: Stock Falls 4% as an $8.5 Billion Breakup Meets a Guidance Cut

2026-10-21

Abbott Laboratories is splitting itself in two. The healthcare giant said Wednesday it will separate its nutrition business — home to Similac infant formula, Pedialyte and Ensure — into an independ...